Methylene Blue IV™

Service Description

Methylene Blue IV™ is a standalone photodynamic oncology therapy designed to exploit methylene blue’s photosensitizing properties when activated by intravenous red-light laser therapy. Upon red-light activation, methylene blue generates targeted oxidative and mitochondrial stress , disrupting tumor bioenergetics, impairing electron transport, and inducing apoptosis signaling while sparing surrounding tissue. This protocol is not a nutritional IV and is not combinable with other active IV therapies. It is reserved for carefully screened oncology patients and administered under strict medical oversight.